IBO
Impact BioMedical Inc.
NYSE AmericanUSDEQUITY
Healthcare
DELAYED
Strong sell
-84/100
Last price
4.51
▼ 0.17 (3.63%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
4.68
Prev close
4.68
Day high
4.59
Day low
4.51
Volume
3.33K
Market cap
$38.53M
P/E (TTM)
0.41
52W range
4.43 – 10.51
Day trading desk
Gap from prior close
+0.00%
Prior close 4.68
VWAP
4.58
-1.45% from price
Relative volume
0.17×
Quiet session
Session range
3.77%
4.51 – 4.68
Position in range
0%
Near session low
ATR (14D)
0.63
13.86% of price
Prior day high
5.05
PDH
Prior day low
4.43
PDL
Bid / ask spread
—
Quote not published
Session volume
1.99K
Avg 11.49K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-19.46%
-21.0%
1M
-28.74%
-29.9%
3M
-21.35%
-24.4%
6M
-49.82%
-64.4%
YTD
-29.45%
-43.0%
1Y
-44.07%
-59.4%
3Y
—
-81.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on IBO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-6.32M
Net selling
Buy transactions
6
61.05K shares
Sell transactions
11
6.38M shares
Net transactions
+17
Buys less sells
Sell : buy shares
104.5 : 1
Heavily one-sided
Insider-held shares
7.61M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 27, 26 | MACKO TODD D. Chief Financial Officer |
SELL | 45.00K | $25.33K | Direct |
| Mar 23, 26 | GRADY JASON Director |
SELL | 50.00K | $32.51K | Direct |
| May 27, 25 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 161.00K | $88.01K | Direct |
| Apr 4, 25 | CHAN HENG FAI AMBROSE Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.69M | $996.40K | Indirect |
| Apr 4, 25 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 890.80K | $845.01K | Direct |
| Apr 3, 25 | CHAN HENG FAI AMBROSE Director |
SELL | 351.56K | $174.02K | Indirect |
| Apr 1, 25 | CHAN HENG FAI AMBROSE Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 2.53M | $2.20M | Indirect |
| Mar 27, 25 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 605.62K | $2.73M | |
| Mar 20, 25 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
BUY | 200 | $416 | Indirect |
| Mar 20, 25 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 53.30K | $110.88K | Indirect |
| Dec 5, 24 | HEUSZEL FRANK D. Chief Executive Officer |
BUY | 500 | $1.13K | Direct |
| Nov 27, 24 | HEUSZEL FRANK D. Chief Executive Officer |
BUY | 500 | $1.30K | Direct |
| Nov 26, 24 | HEUSZEL FRANK D. Chief Executive Officer |
BUY | 1.05K | $2.74K | Direct |
| Nov 18, 24 | DSS INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 5.70K | $17.02K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHAN HENG FAI AMBROSE |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Sale |
DSS INC. |
Beneficial Owner of more than 10% of a Class of Security | 0 | Sale |
GRADY JASON |
Director | 250.18K | Sale |
HEUSZEL FRANK D. |
Chief Executive Officer | 97.34K | Purchase |
MACKO TODD D. |
Chief Financial Officer | 155.12K | Sale |
Fundamentals
Market cap$38.53M
Enterprise value$43.22M
Revenue (TTM)$35.00K
Gross profit$-389.00K
EBITDA$-3.95M
Net income$791.00K
EPS (TTM)$11.11
Free cash flow$1.02M
Total cash$10.00K
Total debt$0
Book value / share$1.26
Shares outstanding8.54M
Float910.34K
Short % of float4.49%
Dividend yield0.00%
Beta (5Y)2.73
Valuation & profitability ratios
Trailing P/E0.41
Forward P/E—
PEG ratio—
Price / sales—
Price / book3.58
EV / revenue1,234.88
EV / EBITDA-10.94
Gross margin0.00%
Operating margin-23400.00%
Profit margin2260.00%
Return on equity23.46%
Return on assets-17.79%
Debt / equity9.49
Current ratio0.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $32.00K | $0 | $0 | $50.00K | — |
| Operating revenue | $32.00K | $0 | $0 | $50.00K | — |
| Cost of revenue | $424.00K | $0 | — | — | — |
| Gross profit | -$392.00K | $0 | — | — | — |
| Research & development | $340.00K | $278.00K | $1.69M | $1.23M | +22.3% |
| Selling, general & admin | $1.98M | $1.83M | $1.10M | $1.05M | +8.0% |
| Total operating expense | $3.88M | $3.40M | $4.03M | $3.45M | +14.2% |
| Operating income | -$4.27M | -$3.40M | -$4.03M | -$3.40M | -25.7% |
| Net interest income | -$780.00K | -$1.05M | -$431.00K | -$438.00K | +25.9% |
| Pre-tax income | -$14.45M | -$24.74M | -$4.41M | -$7.88M | +41.6% |
| Tax provision | -$2.58M | $33.00K | $0 | -$621.00K | -7,918.2% |
| Net income | -$11.84M | -$24.71M | -$4.34M | -$7.05M | +52.1% |
| Net income to common | -$11.84M | -$24.71M | -$4.34M | -$7.05M | +52.1% |
| Basic EPS | -0.38 | -2.30 | -0.07 | -0.61 | +83.5% |
| Diluted EPS | -0.38 | -2.30 | -0.07 | -0.61 | +83.5% |
| EBIT | -$13.66M | -$23.67M | -$3.96M | -$7.41M | +42.3% |
| EBITDA | -$12.51M | -$22.55M | -$2.84M | -$6.30M | +44.5% |
| Basic shares | 31.55M | 10.76M | 60.25M | 11.50M | +193.3% |
| Diluted shares | 31.55M | 10.76M | 60.25M | 11.50M | +193.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.00K | $2.00M | $1.00K | $2.00K | — | -99.8% |
| Cash & short-term investments | $3.00K | $2.00M | $1.00K | $2.00K | — | -99.8% |
| Accounts receivable | $5.00K | $0 | — | — | — | — |
| Inventory | $63.00K | $0 | — | — | — | — |
| Total current assets | $411.00K | $2.45M | $332.00K | $122.00K | — | -83.2% |
| Property, plant & equipment | $0 | $17.00K | $287.00K | $276.00K | — | -100.0% |
| Goodwill & intangibles | $16.99M | $17.81M | $44.01M | $45.13M | — | -4.6% |
| Total assets | $17.41M | $20.29M | $44.63M | $46.50M | — | -14.2% |
| Total current liabilities | $1.16M | $9.79M | $13.14M | $10.59M | — | -88.1% |
| Current debt | — | $8.88M | $12.07M | $9.99M | $12.52M | — |
| Total debt | — | $8.88M | $12.07M | $9.99M | $12.52M | — |
| Total liabilities | $1.85M | $13.05M | $16.37M | $13.83M | — | -85.8% |
| Retained earnings | -$49.51M | -$37.67M | -$12.96M | -$8.63M | — | -31.4% |
| Shareholder equity | $12.61M | $4.26M | $25.22M | $29.56M | — | +196.1% |
| Working capital | -$751.00K | -$7.34M | -$12.80M | -$10.47M | — | +89.8% |
| Net tangible assets | -$4.38M | -$13.55M | -$18.79M | -$15.57M | — | +67.6% |
| Shares issued | 104.62M | 11.50M | 11.50M | 11.50M | — | +809.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.87M | -$24.77M | -$4.41M | -$7.25M | — | +52.1% |
| Depreciation & amortisation | $1.15M | $1.12M | $1.12M | $1.11M | — | +2.3% |
| Stock-based compensation | $13.00K | $19.00K | $0 | — | — | -31.6% |
| Change in working capital | $600.00K | -$608.00K | $436.00K | $421.00K | — | +198.7% |
| Operating cash flow | -$1.89M | -$2.85M | -$2.85M | -$2.24M | — | +33.8% |
| Capital expenditure | — | — | -$18.00K | -$276.00K | -$276.00K | — |
| Investing cash flow | $3.00K | $2.00K | -$15.00K | -$349.00K | — | +50.0% |
| Financing cash flow | -$109.00K | $4.85M | $2.87M | $2.55M | — | -102.2% |
| Free cash flow | -$1.89M | -$2.85M | -$2.87M | -$2.52M | — | +33.8% |
| End cash position | $3.00K | $2.00M | $1.00K | $2.00K | — | -99.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $3.00K | $7.00K | $7.00K | $18.00K | $7.00K | — | -57.1% |
| Operating revenue | $3.00K | $7.00K | $7.00K | $18.00K | $7.00K | — | -57.1% |
| Cost of revenue | $1.00K | — | $422.00K | $1.00K | $1.00K | — | — |
| Gross profit | $2.00K | — | -$415.00K | $17.00K | $6.00K | — | — |
| Research & development | $76.00K | $46.00K | $110.00K | $52.00K | $75.00K | — | +65.2% |
| Selling, general & admin | $277.00K | $1.90M | $275.00K | $516.00K | $676.00K | — | -85.4% |
| Total operating expense | $704.00K | $2.30M | $743.00K | $965.00K | $1.16M | — | -69.3% |
| Operating income | -$702.00K | -$2.29M | -$1.16M | -$948.00K | -$1.15M | — | +69.3% |
| Net interest income | $2.00K | $5.00K | $3.00K | -$259.00K | -$257.00K | — | -60.0% |
| Pre-tax income | -$700.00K | -$2.28M | $2.65M | -$1.48M | -$14.35M | — | +69.4% |
| Tax provision | $0 | $0 | -$2.58M | $0 | $0 | — | — |
| Net income | -$699.00K | -$2.29M | $5.25M | -$1.47M | -$14.35M | — | +69.4% |
| Net income to common | -$699.00K | -$2.29M | $5.25M | -$1.47M | -$14.35M | — | +69.4% |
| Basic EPS | -0.01 | -0.02 | — | -0.12 | -1.18 | -0.11 | +50.0% |
| Diluted EPS | -0.01 | -0.02 | — | -0.12 | -1.18 | -0.11 | +50.0% |
| EBIT | -$700.00K | -$2.28M | $2.65M | -$1.21M | -$14.09M | — | +69.4% |
| EBITDA | -$416.00K | -$2.00M | $2.94M | -$925.00K | -$13.80M | — | +79.2% |
| Basic shares | 107.82M | 107.79M | — | 12.19M | 12.19M | 12.06M | +0.0% |
| Diluted shares | 107.82M | 107.79M | — | 12.19M | 12.19M | 12.06M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10.00K | $20.00K | $3.00K | $12.00K | $624.00K | — | -50.0% |
| Cash & short-term investments | $10.00K | $20.00K | $3.00K | $12.00K | $624.00K | — | -50.0% |
| Accounts receivable | $0 | $0 | $5.00K | $15.00K | — | $4.00K | — |
| Inventory | $62.00K | $63.00K | $63.00K | $485.00K | $486.00K | — | -1.6% |
| Total current assets | $320.00K | $377.00K | $411.00K | $917.00K | $1.48M | — | -15.1% |
| Property, plant & equipment | — | — | $0 | $13.00K | $14.00K | $16.00K | — |
| Goodwill & intangibles | $16.43M | $16.71M | $16.99M | $17.28M | $17.57M | — | -1.7% |
| Total assets | $16.75M | $17.09M | $17.41M | $18.21M | $19.06M | — | -2.0% |
| Total current liabilities | $2.04M | $1.69M | $1.16M | $23.79M | $23.17M | — | +21.2% |
| Current debt | — | — | — | $22.88M | $22.35M | $9.14M | — |
| Total debt | — | — | — | $22.88M | $22.35M | $9.14M | — |
| Total liabilities | $2.73M | $2.38M | $1.85M | $27.06M | $26.44M | — | +15.1% |
| Retained earnings | -$52.49M | -$51.79M | -$49.51M | -$54.75M | -$53.28M | — | -1.3% |
| Shareholder equity | $10.77M | $11.46M | $12.61M | -$11.81M | -$10.34M | — | -6.1% |
| Working capital | -$1.73M | -$1.31M | -$751.00K | -$22.88M | -$21.69M | — | -31.7% |
| Net tangible assets | -$5.66M | -$5.25M | -$4.38M | -$29.09M | -$27.91M | — | -7.9% |
| Shares issued | 107.82M | 107.82M | 104.62M | 12.19M | 12.19M | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$699.00K | -$2.28M | $5.24M | -$1.47M | -$14.35M | — | +69.4% |
| Depreciation & amortisation | $284.00K | $285.00K | $286.00K | $288.00K | $288.00K | — | -0.4% |
| Stock-based compensation | $0 | $1.44M | $8.00K | $1.00K | -$27.00K | — | -100.0% |
| Change in working capital | $885.00K | $95.00K | $541.00K | $42.00K | $6.00K | — | +831.6% |
| Operating cash flow | $470.00K | -$464.00K | $99.00K | -$613.00K | -$694.00K | — | +201.3% |
| Investing cash flow | $2.00K | -$1.00K | $1.00K | $1.00K | $0 | — | +300.0% |
| Financing cash flow | — | $482.00K | -$109.00K | $0 | $0 | $0 | — |
| Free cash flow | $470.00K | -$464.00K | $99.00K | -$613.00K | -$694.00K | — | +201.3% |
| End cash position | $10.00K | $20.00K | $3.00K | $12.00K | $624.00K | — | -50.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders89.02%
Held by institutions3.56%
Institutions holding22
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.29
-14.79% from price
SMA 20
5.93
-23.89% from price
SMA 50
5.83
-22.63% from price
SMA 100
6.09
-25.99% from price
SMA 200
6.52
-30.85% from price
EMA 12
5.38
-16.20% from price
EMA 26
5.72
-21.10% from price
EMA 50
5.88
-23.27% from price
RSI (14)
32.0
Neutral
MACD (12,26,9)
-0.33
Hist -0.21
ATR (14)
0.63
13.86% of price
Realised vol 30D
100.3%
Annualised
Bollinger upper
7.54
20, 2σ
Bollinger lower
4.31
20, 2σ
50 / 200 cross
Death
5.83 vs 6.52
Trend bias
Below 200
-30.85%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.86
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
100.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-54.3%
Peak to trough
Max drawdown 5Y
-92.8%
Peak to trough
ATR 14
0.63
13.86% of price
Beta (reported)
2.73
5Y monthly, from filing
Short interest
Shares short
41.76K
Prior 43.32K
Change vs prior
-3.6%
Shorts covering
% of float
4.49%
Normal
% of shares out
0.49%
Against total outstanding
Days to cover
2.0
Liquid
Float
910.34K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split79:1000
Split dateSep 23, 2026
SEC filings
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-17
Corporate Changes & Voting Matters
8-K · 2026-09-15
Periodic Financial Reports
10-Q · 2026-08-07
Periodic Financial Reports
10-Q · 2026-05-12
Offering Registrations
S-8 POS · 2026-04-22
Offering Registrations
S-8 POS · 2026-04-06
Periodic Financial Reports
10-K · 2026-03-11
Corporate Changes & Voting Matters
8-K · 2026-03-04
Headlines
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
GlobeNewswire · 21d ago
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
GlobeNewswire · 21d ago
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
GlobeNewswire · 23d ago
Impact BioMedical to Effect 1-for-12.62 Reverse Stock Split
MT Newswires · 26d ago
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
GlobeNewswire · 26d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.